HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cristina Vila Selected Research

cizolirtine

7/2022Results from two-year rodent oral carcinogenicity studies of cizolirtine, a substance-P and calcitonin gene-related peptide release modulator.
6/2021Twenty six-week repeat dose oral rat toxicity study of cizolirtine, a substance-P and calcitonin gene-related peptide release modulator.
2/2021Assessment of the Genotoxic Potential of Cizolirtine a Substance-P and Calcitonin Gene-Related Peptide Release Modulator.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cristina Vila Research Topics

Disease

3Urinary Incontinence
07/2022 - 02/2021
2Pain (Aches)
07/2022 - 06/2021
1Sarcoma (Soft Tissue Sarcoma)
07/2022
1Fibrosarcoma
07/2022
1Adenocarcinoma of Lung
01/2022
1Adenocarcinoma
01/2022
1Lung Neoplasms (Lung Cancer)
01/2022
1Neoplasms (Cancer)
01/2022
1Chromosome Aberrations (Chromosome Abnormalities)
02/2021
1Hyperglycemia
07/2013
1Insulin Resistance
07/2013

Drug/Important Bio-Agent (IBA)

3cizolirtineIBA
07/2022 - 02/2021
2Calcitonin Gene-Related PeptideIBA
07/2022 - 06/2021
2Substance PIBA
07/2022 - 06/2021
1Pulmonary Surfactant-Associated ProteinsIBA
01/2022
1VimentinIBA
01/2022
1Conditioned Culture MediaIBA
01/2022
1Pharmaceutical PreparationsIBA
02/2021
1Biological ProductsIBA
02/2021
1Insulin (Novolin)FDA Link
07/2013
1Phosphotransferases (Kinase)IBA
07/2013
1Rosiglitazone (Avandia)FDA Link
07/2013

Therapy/Procedure

1Analgesia
02/2021